Silvia Spena/LinkedIn
Jul 1, 2026, 19:36
Silvia Spena: New Evidence Linking miR-128 and Memory T Cells in Severe Hemophilia A
Silvia Spena, Senior Researcher at IRCCS Cà Granda Hospital Major Polyclinics Foundation, shared on LinkedIn about a recent article she and her colleagues co-authored, published in RPTH, adding:
”I am thrilled to share our latest publication in RPTH, which explores the ‘Differential expression of miR-128 in memory T cells of patients with severe hemophilia A with and without inhibitors’.”
Title: Differential expression of miR-128 in memory T cells of patients with severe hemophilia A with and without inhibitors
Authors: Silvia Spena, Andrea Cairo, Emanuela Pappalardo, Calogero C. Tedesco, Roberta Gualtierotti, Flora Peyvandi
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 16, 2026, 09:33Anıl Güneş: The Unseen Threat – How Global Climate Change Impacts Cardiovascular Health
-
Aug 16, 2026, 09:09Robert John Nesbitt: Can We Prevent Stroke Without Increasing Bleeding Risk
-
Aug 16, 2026, 06:19Dennis Wolf: Is ZEUS the End of Anti-Inflammatory Therapy in Atherosclerosis?
-
Aug 16, 2026, 06:05Nicolas Hubacz: A New Target for Stroke Recovery
-
Aug 15, 2026, 19:30José Luis Neyro: E4 and DRSP Reduce Hirsutism While Showing Comparable Effects on Thrombin Generation
-
Aug 15, 2026, 19:27Mahmoud Akraym: Don’t Choose Anticoagulation as the Immediate Treatment for Unstable AF
-
Aug 15, 2026, 19:25Ahmed Bennis: DOACs Increase 1-Year Stroke Risk but Reduce MI Risk Compared With Warfarin
-
Aug 15, 2026, 19:24Megan Adediran: An Unwavering Fight for People Living With Haemophilia
-
Aug 15, 2026, 19:23Intravenous Anticoagulation Linked to Worse Early Outcomes After Noncardioembolic Stroke – International Journal of Stroke